drug discovery

high content analysis 3D

The Future of High Content Analysis is 3D

InSphero and their pharma and biotech partners were eager to exploit the full potential of 3D models through interrogation of specific cell population interactions and extraction of spatial and temporal information. High Content Analysis (HCA), specifically high content imaging, was recognized as a key technology to accomplish these technically challenging goals.

The Future of High Content Analysis is 3D Read More »

Scroll to Top